Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors.
Perelman MG, Brzezinski RY, Waissengrin B, Leshem Y, Bainhoren O, Rubinstein TA, Perelman M, Rozenbaum Z, Havakuk O, Topilsky Y, Banai S, Wolf I, Laufer-Perl M.
Perelman MG, et al. Among authors: leshem y.
Cardiooncology. 2024 Jan 11;10(1):2. doi: 10.1186/s40959-023-00199-6.
Cardiooncology. 2024.
PMID: 38212825
Free PMC article.